BUILDER v.2: improving the chemistry of a de novo design strategy
- PMID: 7561978
- DOI: 10.1007/BF00124457
BUILDER v.2: improving the chemistry of a de novo design strategy
Abstract
Significant improvements have been made to the de novo drug design program BUILDER. The BUILDER strategy is to find molecule templates that bind tightly to 'hot spots' in the target receptor, and then generate bridges to join these templates. In this paper, the bridging algorithm has been further developed to improve the chemical sense and diversity of the bridges, as well as the robustness of the technique. The improved algorithm is then applied to rebuild known bridges in methotrexate and HIV protease. Finally, the entire BUILDER approach is tested by rebuilding methotrexate de novo.
Similar articles
-
The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses.J Med Chem. 1993 Nov 26;36(24):3863-70. doi: 10.1021/jm00076a016. J Med Chem. 1993. PMID: 8254618
-
Free energy perturbation studies on binding of A-74704 and its diester analog to HIV-1 protease.Protein Eng. 1996 Sep;9(9):767-71. doi: 10.1093/protein/9.9.767. Protein Eng. 1996. PMID: 8888142
-
Multiple Target Drug Design Using LigBuilder 3.Methods Mol Biol. 2021;2266:279-298. doi: 10.1007/978-1-0716-1209-5_16. Methods Mol Biol. 2021. PMID: 33759133
-
Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation.Comb Chem High Throughput Screen. 2009 May;12(4):383-96. doi: 10.2174/138620709788167971. Comb Chem High Throughput Screen. 2009. PMID: 19442066 Review.
-
Recent advances in de novo design strategy for practical lead identification.Med Res Rev. 2003 Sep;23(5):606-32. doi: 10.1002/med.10046. Med Res Rev. 2003. PMID: 12789688 Review.
Cited by
-
Computational Methods Applied to Rational Drug Design.Open Med Chem J. 2016 Apr 26;10:7-20. doi: 10.2174/1874104501610010007. eCollection 2016. Open Med Chem J. 2016. PMID: 27708723 Free PMC article.
-
Protein ligand docking based on empirical method for binding affinity estimation.J Comput Aided Mol Des. 2001 May;15(5):429-46. doi: 10.1023/a:1011188704521. J Comput Aided Mol Des. 2001. PMID: 11394737
-
Discovery of a novel serine protease inhibitor utilizing a structure-based and experimental selection of fragments technique.J Comput Aided Mol Des. 2001 Jun;15(6):553-9. doi: 10.1023/a:1011196407163. J Comput Aided Mol Des. 2001. PMID: 11495226
-
A genetic algorithm for structure-based de novo design.J Comput Aided Mol Des. 2001 Oct;15(10):911-33. doi: 10.1023/a:1014389729000. J Comput Aided Mol Des. 2001. PMID: 11918076
-
From laptop to benchtop to bedside: structure-based drug design on protein targets.Curr Pharm Des. 2012;18(9):1217-39. doi: 10.2174/138161212799436386. Curr Pharm Des. 2012. PMID: 22316152 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources